CXCL5 and non-small cell lung carcinoma: TQ treatment (1.25, 2.5 and 5 μM, for 24, 48 and 72 h) of NCI‐H460 cells (NSCLC cell line) reduced cell proliferation, expression of cytokines, epithelial‐neutrophil activating peptide (ENA‐78) and GRO‐alpha and increased apoptosis occurrence and reduced cell viability.47